GlassScriptPhysician profile
Jamie R Williams
NPI 1376113050
$2,286.20
in general payments reported to CMS, 2019-2025
21 companies · $54.99 in 2025
The $54.99 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.61 · 2022: $438 · 2023: $1,194 · 2024: $563 · 2025: $54.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,757 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,757.27 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $474.86 | 2021-2024 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $387.94 | 2022-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Genzyme Corporation | $276.77 | 2022-2024 | |
| Amgen INC. | $220.44 | 2022-2024 | Tezspire, Tavneos |
| Harmony Biosciences LLC | $128.88 | 2023-2025 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $106.60 | 2022-2024 | Glassia |
| Pfizer INC. | $102.04 | 2022-2024 | |
| United Therapeutics Corporation | $94.71 | 2022-2024 | Tyvaso |
| Merck Sharp & Dohme LLC | $90.51 | 2023-2024 | Winrevair |
| Novartis Pharmaceuticals Corporation | $71.89 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $57.07 | 2023 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.19 | 2021-2023 | Spiriva Respimat, Stiolto Respimat |
| Grifols USA, LLC | $44.74 | 2023-2024 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $37.32 | 2024 | Acthar |
| Actelion Pharmaceuticals US, INC. | $32.74 | 2024 | Uptravi |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $27.75 | 2024 | Smartvest |
| Baxter Healthcare | $20.95 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $19.41 | 2023 | |
| Idorsia Pharmaceuticals US INC | $14.42 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $13.59 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.